Systemic mastocytosis: 2023 update on diagnosis and management in adults.
Costa A, Scalzulli E, Carmosino I, Capriata M, Ielo C, Masucci C, Passucci M, Martelli M, Breccia M.
Expert Opin Emerg Drugs. 2023 Dec;28(3):153-165. doi: 10.1080/14728214.2023.2221028. Epub 2023 Jun 6.
Neuropsychological features of adult mastocytosis.
Moura DS, Georgin-Lavialle S, Gaillard R, Hermine O.
Immunol Allergy Clin North Am. 2014 May;34(2):407-22. doi: 10.1016/j.iac.2014.02.001.
Perioperative management of mastocytosis.
Lau S, Sprung J, Volcheck GW, Butterfield JH, Divekar RD, Weingarten TN.
J Anesth. 2023 Oct;37(5):741-748. doi: 10.1007/s00540-023-03228-x. Epub 2023 Jul 19.
Generalized mastocytosis.
van Kammen E.
Acta Haematol. 1974;52(3):129-40. doi: 10.1159/000208232.
Mastocytosis and Anaphylaxis.
Schuch A, Brockow K.
Immunol Allergy Clin North Am. 2017 Feb;37(1):153-164. doi: 10.1016/j.iac.2016.08.017. Epub 2016 Oct 28.
The Prevalence Of Osteoporosis Is Low in Adult Cutaneous Mastocytosis Patients.
Degboé Y, Severino-Freire M, Couture G, Apoil PA, Gaudenzio N, Hermine O, Ruyssen-Witrand A, Paul C, Laroche M, Constantin A, Livideanu CB.
J Allergy Clin Immunol Pract. 2024 May;12(5):1306-1312. doi: 10.1016/j.jaip.2024.02.021. Epub 2024 Feb 27.
Scoring the Risk of Having Systemic Mastocytosis in Adult Patients with Mastocytosis in the Skin.
Fuchs D, Kilbertus A, Kofler K, von Bubnoff N, Shoumariyeh K, Zanotti R, Bonadonna P, Scaffidi L, Doubek M, Elberink HO, Span LFR, Hermine O, Elena C, Benvenuti P, Yavuz AS, Brockow K, Zink A, Aberer E, Gorska A, Romantowski J, Hadzijusufovic E, Fortina AB, Caroppo F, Perkins C, Illerhaus A, Panse J, Vucinic V, Jawhar M, Sabato V, Triggiani M, Parente R, Bergström A, Breynaert C, Gotlib J, Reiter A, Hartmann K, Niedoszytko M, Arock M, Kluin-Nelemans HC, Sperr WR, Greul R, Valent P.
J Allergy Clin Immunol Pract. 2021 Apr;9(4):1705-1712.e4. doi: 10.1016/j.jaip.2020.12.022. Epub 2020 Dec 23.
Adult Onset of Xanthelasmoid Mastocytosis: Report of a Rare Entity.
Nabavi NS, Nejad MH, Feli S, Bakhshoodeh B, Layegh P.
Indian J Dermatol. 2016 Jul-Aug;61(4):468. doi: 10.4103/0019-5154.185751.
Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes.
Polivka L, Madrange M, Bulai-Livideanu C, Barete S, Ballul T, Neuraz A, Greco C, Agopian J, Brenet F, Dubreuil P, Burdet C, Lemal R, Tournilhac O, Terriou L, Launay D, Bouillet L, Gourguechon C, Damaj G, Frenzel L, Meni C, Bouktit H, Collange AF, Gaudy-Marqueste C, Gousseff M, Le Mouel E, Hamidou M, Neel A, Ranta D, Jaussaud R, Guilpain P, Canioni D, Molina TJ, Bruneau J, Lhermitte L, Garcelon N, Javier RM, Pelletier F, Castelain F, Retornaz F, Cabrera Q, Zunic P, Gourin MP, Wierzbicka-Hainaut E, Viallard JF, Lavigne C, Hoarau C, Durieu I, Heiblig M, Dimicoli-Salazar S, Torregrosa-Diaz JM, Soria A, Arock M, Lortholary O, Bodemer C, Hermine O, Rossignol J; CEREMAST network.
J Allergy Clin Immunol. 2024 Jan;153(1):349-353.e4. doi: 10.1016/j.jaci.2023.08.015. Epub 2023 Aug 24.
[Mastocytosis-a frequently unrecognized disease].
Muñoz M, Siebenhaar F.
Dermatologie (Heidelb). 2024 Jan;75(1):75-86. doi: 10.1007/s00105-023-05258-8. Epub 2023 Dec 12.
